Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
Posted on: Monday, 15 June 2009, 08:03 CDT
(Logo: http://www.newscom.com/cgi-bin/prnh/20090612/CTCALOGO)
"While emerging evidence suggests the protective role of vitamin D in cancer, vitamin D status is not routinely assessed in cancer patients despite the high prevalence of malnutrition in this population," said Carolyn Lammersfeld, national director of nutrition for CTCA and a principal investigator in the study.
During the study, a consecutive case series of 737 cancer patients (302 male and 435 female) seen at CTCA between January -
Before the study, the researchers hypothesized that malnutrition could contribute to vitamin D deficiency and therefore expected mean serum 25-hydroxy-vitamin D [25(OH)D] levels to be significantly lower in malnourished oncology patients. However contrary to what they expected, vitamin D deficiency was found to be prevalent in cancer regardless of nutritional status.
This study was presented at the American Society of Clinical Oncology (ASCO) annual meeting,
About Cancer Treatment Centers of America
Founded in 1988, Cancer Treatment Centers of America (CTCA) is a national network of hospitals providing a comprehensive, fully integrative approach to cancer treatment. CTCA serves patients with advanced cancer from all 50 states at facilities located in suburban
SOURCE Cancer Treatment Centers of America
Source: PR Newswire
Related Articles
- New Vitamin Treatment Saves Patients (Including a U.S. Olympic Athlete) from Blinding Eye Disease Without Surgery
- Nursing Research Grants Available to Improve Treatment of Patients With Auto-Immune Diseases and Cancer
- Research Promotes Pro-Active Vitamin D Regimen in Patients With Osteoporosis
- Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
- Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
- NCCN Announces Important Updates to Cancer- and Treatment-Related Anemia Guidelines
- Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study Report No. 27
- Response of Homocysteine, Cystathionine, and Methylmalonic Acid to Vitamin Treatment in Dialysis Patients
- Vitamin E Scare Hurts Cancer Trial; Doctors Say Their Study on Supplement, Prostate Cancer Prevention is Safe
- Results of Phase IIa Study Show That Reverset Has Potential to Reduce HIV Viral Load in Treatment-Experienced Patients
User Comments (0)

RSS Feeds